206 related articles for article (PubMed ID: 17299600)
21. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.
Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780
[TBL] [Abstract][Full Text] [Related]
22. TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells.
Muñoz-García B; Madrigal-Matute J; Moreno JA; Martin-Ventura JL; López-Franco O; Sastre C; Ortega L; Burkly LC; Egido J; Blanco-Colio LM
Cardiovasc Res; 2011 Jan; 89(1):225-33. PubMed ID: 20810696
[TBL] [Abstract][Full Text] [Related]
23. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
24. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
25. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
26. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
[TBL] [Abstract][Full Text] [Related]
27. TWEAK and the central nervous system.
Yepes M
Mol Neurobiol; 2007 Jun; 35(3):255-65. PubMed ID: 17917114
[TBL] [Abstract][Full Text] [Related]
28. Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis.
Wisniacki N; Amaravadi L; Galluppi GR; Zheng TS; Zhang R; Kong J; Burkly LC
Clin Ther; 2013 Aug; 35(8):1137-49. PubMed ID: 23928094
[TBL] [Abstract][Full Text] [Related]
29. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
[TBL] [Abstract][Full Text] [Related]
31. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis.
Chen J; Wei L; Xia Y
Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399
[TBL] [Abstract][Full Text] [Related]
32. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
[TBL] [Abstract][Full Text] [Related]
33. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
34. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
35. Tweak induces mammary epithelial branching morphogenesis.
Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
[TBL] [Abstract][Full Text] [Related]
36. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
37. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.
Yepes M; Brown SA; Moore EG; Smith EP; Lawrence DA; Winkles JA
Am J Pathol; 2005 Feb; 166(2):511-20. PubMed ID: 15681834
[TBL] [Abstract][Full Text] [Related]
38. TWEAK/Fn14 signaling in tumors.
Hu G; Zeng W; Xia Y
Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
[TBL] [Abstract][Full Text] [Related]
39. A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.
Benicchi T; Iozzi S; Svahn A; Axelsson H; Mori E; Bernocco S; Cappelli F; Caramelli C; Fanti P; Genesio E; Maccari L; Markova N; Micco I; Porcari V; Schultz J; Fecke W
J Biomol Screen; 2012 Aug; 17(7):933-45. PubMed ID: 22644269
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of the canine cytokine TWEAK (CD255) and its receptor, Fn14 (CD266).
Zhang JX; Sang M; Zhao W; Ai HX; Shui Y; Li JF; Song R; Zhang SQ
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):172-5. PubMed ID: 20452679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
